SC Dismisses Plea for Mandatory Disclosure of Drug Side Effects by Doctors
New Delhi, Nov 14, 2024 — The Supreme Court on Thursday dismissed a public interest litigation (PIL) that sought a mandate for medical professionals to inform patients about all potential side effects and risks associated with the drugs they prescribe. The plea was rejected on the grounds of practicality and concerns over the feasibility of such a requirement.
Background of the Case
The petition, filed by Jacob Vadakkanchery, was an appeal against the Delhi High Court’s May 15 order, which had rejected the same request. The petition called for a direction to the Centre and National Medical Commission to enforce a rule requiring doctors to include a detailed list of side effects along with every prescription, potentially in the regional language, to enable patients to make an informed decision.
Supreme Court’s Observations
A bench of Justices B R Gavai and K V Viswanathan acknowledged that while the issue raised was significant, they did not find it practical to implement the mandate as suggested. The bench noted that it would place an undue burden on general practitioners, who may struggle to manage the increasing number of patients if they were required to explain every potential side effect for each drug prescribed.
- Feasibility Concerns: The court remarked that if the proposal were to be implemented, doctors might only be able to treat a small number of patients, which could lead to medical negligence cases under the Consumer Protection Act.
- Consumer Protection: Bhushan, appearing for the petitioner, argued that having a printed proforma or slip listing possible side effects would help doctors avoid negligence and empower patients to make an informed choice.
The Argument for Informed Choice
Bhushan emphasized that patients have the right to make an informed choice about the medicines they are prescribed. He pointed to the World Health Organization’s (WHO) acknowledgment of the harm that can occur from incorrect or insufficiently explained prescriptions.
However, the court reiterated that the legislature had already imposed the responsibility on drug manufacturers and pharmacists to provide necessary information on side effects through inserts that accompany medicines at the time of sale.
Delhi High Court’s Rejection and Court’s Final Ruling
In its earlier ruling, the Delhi High Court had rejected the PIL, observing that judicial legislation could not be introduced in this matter since the legislative duty to provide information already rested with the manufacturer and pharmacist. The high court noted that the petitioner had not disputed the sufficiency of the information already provided by the drug manufacturer through the product insert.
The Supreme Court upheld the High Court’s decision, stating that the duty to ensure adequate information about drug risks already lay with the manufacturer and pharmacist, and there was no need for a fresh mandate from the judiciary.
Conclusion
The Supreme Court’s ruling dismisses the plea to make it mandatory for doctors to provide a comprehensive list of potential risks and side effects of prescribed drugs. The court cited practicality concerns, the existing role of manufacturers and pharmacists in providing such information, and the potential burden on doctors in implementing such a mandate.
This ruling emphasizes the importance of clarity in the existing healthcare system and the separation of powers between the judiciary and legislature in determining responsibilities within medical practice.
